Teleflex to Present at Morgan Stanley Global Healthcare Conference.

Teleflex Incorporated, a global provider of medical technologies, will present at the Morgan Stanley 23rd Annual Global Healthcare Conference on September 9, 2025. A live audio webcast of the presentation will be available on the company's website. Teleflex offers a diverse portfolio of solutions in various therapy areas, including anesthesia, emergency medicine, and interventional cardiology. The company aims to become the most trusted partner in healthcare through its vision and purpose.

Teleflex Incorporated (NYSE: TFX), a global leader in medical technologies, has announced its participation in the Morgan Stanley 23rd Annual Global Healthcare Conference. The presentation, scheduled for Tuesday, September 9, 2025, at 3:20 p.m. ET, will take place at the Sheraton New York Times Square. Investors can access the live audio webcast through the company's investor relations website at teleflex.com [1].

Teleflex, driven by its purpose to improve the health and quality of people’s lives, offers a diverse portfolio of solutions in various therapy areas, including anesthesia, emergency medicine, interventional cardiology, radiology, surgical, vascular access, and urology. The company is committed to becoming the most trusted partner in healthcare through its vision and purpose-driven innovation [2].

The upcoming presentation at the Morgan Stanley conference is an opportunity for investors to gain insights into Teleflex's strategic direction, recent achievements, and future prospects. The company has recently expanded its product offerings, with notable additions such as the Barrigel rectal spacer, which has been approved for use in Japan following regulatory approval and insurance coverage acceptance [3].

Teleflex's portfolio includes well-known brands such as Arrow™, Barrigel™, Deknatel™, QuikClot™, LMA™, Pilling™, Rüsch™, UroLift™, and Weck™, all united by a common sense of purpose. The company's mission to empower the future of healthcare is evident in its commitment to developing innovative medical technologies that enhance patient outcomes and improve the quality of life for individuals worldwide [2].

Investors and financial professionals are encouraged to tune in to the live audio webcast to learn more about Teleflex's latest developments and strategic initiatives. For more information, please visit teleflex.com.

References:
[1] https://www.stocktitan.net/news/TFX/teleflex-to-present-at-the-morgan-stanley-23rd-annual-global-fwnf3cdh9fxp.html
[2] https://www.globenewswire.com/news-release/2025/08/26/3139101/0/en/Teleflex-to-Present-at-the-Morgan-Stanley-23rd-Annual-Global-Healthcare-Conference.html
[3] https://www.marketscreener.com/news/teleflex-incorporated-announces-the-launch-of-barrigel-rectal-spacer-in-japan-as-a-proven-safe-and-e-ce7c51ddd88cf623